Ellie Kelepouris, MD

faculty photo
Professor of Clinical Medicine (Renal-Electrolyte and Hypertension)
Director, Dialysis Programs, The Hospital of the University of Pennsylvania
Department: Medicine

Contact information
The University of Pennsylvania
1 Founders, 3400 Spruce Street
Philadelphia, PA 19104
Education:
MD (Medicine)
University of Athens School of Medicine; Athens, Greece, 1976.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

I have organized Professional Development Seminars for internal Medicine and Nephrology for faculty and fellows. In 2019 while at the Drexel University College of Medicine, I co-organized a "Physician Burnout Seminar led by Dr. Tait Shanefelt, currently at Stanford which was attended by 30 mid-career faculty. Additionally, while at Drexel University College of Medicine, I organized a "Career Development and Mentoring" seminar with Dr. Darilyn Moyer, EVP of the American College of Physicians for Internal Medicine Residents and junior faculty.

As Chair of the MAB of the NKF/DV, I am organizing 4 Renal Round table meetings for academic and community Nephrologists (2023-24). The content will be New and Innovative Treatments of CKD, IgA Nephropathy Update, Anemia of CKD, KDIGO 2023 guidelines: Optimizing Treatment of Diabetic Kidney Disease.

Description of Other Expertise

Curricular Development: I have a robust 20 year experience in curricular development at both the fellowship and medical student levels. I was the architect of the Doctoring curriculum while at Temple University - a longitudinal 4 year curriculum for medical students which encompasses case studies with simulation standardized patients, small group discussions and lecture formats. In addition, I developed assessment tools for this new curriculum.

Most recently, with the University of Pennsylvania School of Medicine, I co-developed an innovative educational program in Philadelphia. "The Mid Atlantic 1st Year Renal Fellows Symposium". A curriculum was created to introduce new first year renal fellows in the tri-state area to the challenges they will face in the first 2 months of fellowship. A "boot-camp" - 33 fellows attended from programs in Pennsylvania, Maryland, New Jersey and Delaware. The format was didactic sessions, lectures, small group sessions and case-based formats.

I also spearheaded the Professional Education Initiative for the National Kidney Foundation of the Delaware Valley. I developed a state-of-the-art curriculum with CME for Nephrologists and Primary Care Doctors which showcased clinical and research topics presented by national speakers.

Selected Publications

Quinn, G., Greene, S, Sauer, A., Anker, S.D., Bohm, M., Bozkurt, B., Butler, J., Cleland, J.G., Coats, A.J.S., Desai, N., Pinto, F., Rosano, G., Brandes, C,M, Donachie, V., Kelepouris, E.: Optimisation of renin-angiotensin-aldosterone system inhibitors use in chronic kidney disease patients with heart failure: is hyperkalemia barrier? European Society of Cardiology: Heart Failure Association. Belgrade, Serbia Page: 16-20, May 2025.

Martinez, O.C., Greene, S., Anker, S, Bozkurt, B, Butler, J., Cleland, J.G., Desai, N, Grobbee, D, Kelepouris, E. Rosano, G, Brandes, C.M., Donachie, V, Sauer, A.: Real-world use and effectiveness of patiromer among patients with heart failure at high risk of hyperkalemia: insights from the CARE-HK in HF registry. European Heart Failure Association - Belgrade, Serbia May 2025.

G. Quinn, S.J. Greene, A.J. Sauer, S.D. Anker, M. Bloom, B. Bozkurt, J. Butler, J.G.F. Cleland, A.J.S. Coats, N.R. Desai, F. Pinto, G. Rosano, Brandes, C-M, V. Donachie and Kelepouris, E.: Optimisation of renin-angiotensin-aldosterone system inhibitors use in chronic kidney disease patients with heart failure: is hyperkalemia a barrier? European Heart Failure Association, Belgrade, Serbia May 2025.

Kelepouris, E., Desai, N., Kosirobod, M., Budden, J., Boehm, M.: Collaborative Management o Hyperkalemia in Patients with Complex Heart Failure. Case Reports in Nephrology and Dialysis, Case Reports January 2025.

Martinez, O.C., Greene, S., Anker, S., Bozkurt, B., Butler, J., Cleland, J.G., Desai, N., Grobbee, D., Kelepouris, E., Rosano, G., Brandes, C.M., Donachie, V., Sauer, A.,: Real-world use and effectiveness of patiromer among patients with heart failure at high risk of hyperkalemia: insights from the CARE-HK in HF registry. EHA 2025.

E. Kelepouris, N. Desai, K.A.A. Clark, M.N. Kosiborod, J. Budden, S. Waechter, and M. Bohm: Collaborative management of hyperkalemia in patients with complex heart failure. Journal Case Reports in Nephrology and Dialysis December 2024.

Rastogi A, Chertow GM, Collins A, Kelepouris E, Kotzker W, Middleton JP, Rajpal M, Roy-Chaudhury P.: Utilization of Potassium Binders for the Management of Hyperkalemia in Chronic Kidney Disease: A Position Statement by US Nephrologists. Adv Kidney Dis Health 31(6): 514-522, Nov 2024.

A. Rastogi, A. Collins, E. Kelepouris, W. Kotzker, J.P. Middleton, M. Rajpal, P. Roy-Chaudhury and G.M. Chertow: Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists. Journal of Primary Care and Community Health 15: 21501319241259905, August 14 2024.

S.J. Greene, M. Bohn, B. Bozkurt, J. Butler, J.G.F. Cleland, A.J.S. Coats, N.R. Desai, D.E.Grobbee, E. Kelepouris, F. Pinto, G. Rosano, I. Morin, P. Szecsody, S. Fabien, S. Waechter, M.G. Crespo-Leiro, M. Hulsmann, T. Kempf, O. Pfister, A-C Pouleur, A.J. Sauer, M. Saxena, M. Schulz, M. Volterrani, S.D. Anker and M. Kosiborod: Cardiovascular and Renal Treatment in Heart Failure Patients with Hyperkalemia or high risk of Hyperkalemia: Rationale and Design of the CARE-HK in HF Registry. J. of Cardiac Failure. Elsevier Inc. 00: 1-11, August 2024.

Kelepouris, E. Rovin,B: Approach to the patient with Nephrotic Syndrome. Up to Date 2024.

back to top
Last updated: 01/27/2025
The Trustees of the University of Pennsylvania